ArticleBMC cancer2012

α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial.

Yasuto Akiyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.